CD160 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CD160 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD160 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunofluorescence (IF), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: CD160 Polyclonal Antibody detects endogenous levels of CD160 protein. CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is |
| Immunogen | Immunogen: Synthesized peptide derived from the internal region of human CD160 at AA range: 40-120 |
| Other Names | [Rabbit CD160; CD160; BY55; CD160 antigen; Natural killer cell receptor BY55; CD antigen CD160] |
| Gene, Accession # | [CD160], Gene ID: 11126, NCBI: NP_008984.1, UniProt: O95971 |
| Catalog # | MBS9701623 |
| Price | $130, $220, $325 |
| Order / More Info | CD160 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies